GlassScriptPhysician profile
Molly Dee Heath
NPI 1629647706
$1,794.13
in general payments reported to CMS, 2019-2025
11 companies · $626 in 2025
The $626 reported for 2025 was more than what 79% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $191 · 2023: $307 · 2024: $670 · 2025: $626.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,603.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,603.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $430.01 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Solventum Corporation | $416.89 | 2024-2025 | Activ.A.C., 3m Cavilon, 3m Coban |
| Kci USA, INC. | $363.70 | 2022-2023 | V.A.C. Veraflo, Activ.A.C., 3m Coban |
| Mimedx Group, INC. | $129.42 | 2024-2025 | |
| Smith+Nephew, INC. | $126.53 | 2023-2025 | Renasys Go V2 Home, Renasys Touch, Collagenase Santyl |
| Hydrofera LLC | $117.64 | 2022-2024 | Hydrofera Blue Classic, Cutimed Sorbact, Hydrofera Blue Ready - Border |
| Hartmann USA, INC. | $73.40 | 2022-2025 | Zetuvit Plus 10x10 P10 |
| Convatec INC. | $49.84 | 2023 | |
| Organogenesis INC. | $38.54 | 2024 | |
| Urgo Medical North America, LLC | $38.52 | 2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Cashflow Solutions, LLC | $9.64 | 2024 | Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White, Pcd-51 731a (US) - White |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Molly Heath listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.